ArticleCell and tissue research2025
Panx1a modulates metabolic stress signaling and synaptic composition in the developing zebrafish brain.
Article in Cell and tissue research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From channels to communication networks: a perspective on connexins, pannexins and innexins.Cell and tissue research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pannexin 1a (Panx1a), a neuronal ATP-release channel, is increasingly recognized for its role in neurodevelopment, yet its contribution to synaptic homeostasis under metabolic stress remains poorly defined. We demonstrate that Panx1a coordinates synaptic and metabolic processes supporting neural circuit stability in the developing zebrafish brain. Using a genetic Panx1a knockout model and pharmacological induction of oxidative stress via MPTP, we reveal that Panx1a loss exacerbates metabolic alterations, reduces extracellular ATP availability, and triggers transcriptional activation of AMPK-mTORC1 signaling, autophagy, and apoptosis. These molecular changes coincide with impaired synaptic gene expression and increased neuronal cell death, particularly in the tectum and pallium. Electrophysiological recordings further show that Panx1a may function as a regulator for preserving local field potential coherence and phase-amplitude coupling, with knockout larvae displaying aberrant oscillatory activity and reduced network adaptability. Our findings identify Panx1a as a regulator of the metabolic-synaptic interface during a vulnerable developmental window and suggest that its ablation could contribute to pathophysiological mechanisms underlying neurodevelopmental disorders.
Indexed as
Identifiers
41217516What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.